Services
We undertake the following types of projects across the full spectrum of therapeutic areas and on all classes of small molecule druggable targets:
-
Hit identification
-
Hit-to-lead
-
Lead optimisation
-
Assay development and screening
-
Biomarker identification and pharmacodynamics evaluation
-
Backup series provision
-
Drug de-risking, including pharmaceutics
-
Complete drug discovery from target to clinical candidate nomination, including ‘fast follower' programmes
To enhance our internal expertise and broaden the range of our capabilities, Argenta follows an
alliance model to gain access to state-of-the-art technology and capabilities for our clients.